The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-3-(4-amino-7-(3-hydroxypropyl)-5-p-tolyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)acrylonitrile ID: ALA4069201
PubChem CID: 56840684
Max Phase: Preclinical
Molecular Formula: C19H19N5O
Molecular Weight: 333.40
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(-c2c(/C=C/C#N)n(CCCO)c3ncnc(N)c23)cc1
Standard InChI: InChI=1S/C19H19N5O/c1-13-5-7-14(8-6-13)16-15(4-2-9-20)24(10-3-11-25)19-17(16)18(21)22-12-23-19/h2,4-8,12,25H,3,10-11H2,1H3,(H2,21,22,23)/b4-2+
Standard InChI Key: LPADWFDQODOOMS-DUXPYHPUSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
15.5064 -5.7082 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.5053 -6.5355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2201 -6.9484 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.2182 -5.2954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9337 -5.7045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9385 -6.5355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7304 -6.7877 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.2150 -6.1125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7224 -5.4432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9899 -7.5708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4415 -8.1871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7009 -8.9701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1525 -9.5865 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.2158 -4.4704 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.9728 -4.6570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7780 -4.4863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0284 -3.7011 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4725 -3.0904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6630 -3.2701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4164 -4.0551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7218 -2.3039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0399 -6.1076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4566 -6.8197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2816 -6.8147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1099 -6.8126 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
7 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
4 14 1 0
9 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
18 21 1 0
8 22 1 0
22 23 2 0
23 24 1 0
24 25 3 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 333.40Molecular Weight (Monoisotopic): 333.1590AlogP: 2.91#Rotatable Bonds: 5Polar Surface Area: 100.75Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.05CX LogP: 2.34CX LogD: 2.32Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.70Np Likeness Score: -0.46
References 1. Jackson PA, Widen JC, Harki DA, Brummond KM.. (2017) Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions., 60 (3): [PMID:27996267 ] [10.1021/acs.jmedchem.6b00788 ]